Strength
50 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462053670
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
4/22/2026
Active Ingredients
IMIQUIMODApproval Type
Generic (ANDA)
FDA Application
ANDA201994On Market Since
3/6/2012
Pharmacological Classes
Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers